Skip to the page

Data / Form D filings / Vitranu, Inc.

Vitranu, Inc.: Form D filing

Vitranu, Inc., a biotechnology company in Columbus, OH, filed a Form D with the SEC in 2021. The latest, on October 25, 2021, reports $1.5 million sold of a $3 million offering to 13 investors.

Find out what Vitranu, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7720 RIVERS EDGE DRIVE, SUITE 101, Columbus, OH, 43235
Phone
(404) 697-4853
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1890125

The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 25, 2021New notice$3,000,000$1,511,000$1,489,00013Oct 13, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Wayne EmbreeDirector
Gordon BethwaiteExecutive Officer, Director
Brad BeaseckerExecutive Officer
Gary CharbonneauDirector
Robin SearsDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Oct 25, 2021 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Vitranu, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.